Understanding Left Ventricular Assist Devices

被引:21
作者
Aissaoui, Nadia [1 ,2 ]
Jouan, Jerome [3 ]
Gourjault, Melissa [4 ]
Diebold, Benoit [4 ]
Ortuno, Sofia [1 ]
Hamdan, Amer [1 ]
Latremouille, Christian [3 ]
Pirracchio, Romain [5 ]
Morshuis, Michiel [6 ]
机构
[1] Univ Paris 05, HEGP, AP HP, Dept Crit Care Unit, Paris, France
[2] INSERM, U970, Paris Cardiovasc Res Ctr, Paris, France
[3] Univ Paris 05, HEGP, AP HP, Dept Cardiac Surg, Paris, France
[4] Univ Paris 05, HEGP, AP HP, Dept Cardiol, Paris, France
[5] Univ Paris 05, HEGP, AP HP, Dept Anesthesiol & Intens Care, Paris, France
[6] Ruhr Univ Bochum, Heart & Diabet Ctr NRW, Dept Thorac & Cardiovasc Surg, Bad Oeynhausen, Germany
关键词
Left ventricular assist device; Pump parameters; Bleeding; Pump thrombosis; MECHANICAL CIRCULATORY SUPPORT; HEART-FAILURE; MANAGEMENT; SOCIETY; IMPLANTATION; ARRHYTHMIAS; GUIDELINES; THROMBOSIS; CONSENSUS; PUMP;
D O I
10.1159/000491872
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity. Depending on the assisted ventricles, 3 categories of long-term assist devices are available: left ventricular assist device (LVAD), bi-ventricular assist device and total artificial heart. Improvements in technology, especially the advent of smaller, durable continuous flow pumps, have led to the use of LVADs in a much broader population of patients in the last 10 years. Both the number of patients living with LVADs and the life expectancy of these patients are increasing. Regarding this growing number of patients with LVAD, intensivists need to understand the physiology of the devices, their functioning, potential complications and their management. Methods: We performed a narrative review of relevant medical literature regarding the physiology of patients with LVAD and management of common complications relevant to the critical care physicians. Results: The most frequent complications occurring in the LVAD patients after the post-operative period are bleeding, driveline infections, thrombosis, device malfunction, right ventricular failure and arrhythmias. Bleeding is the most frequent adverse event in LVAD due to a combination of anticoagulation and acquired von Willebrand disease secondary to shear stress produced within the pump. Their management includes antiplatelet therapy arrest, reduction of the anticoagulation regimen and specific therapy if feasible. Infection is the second most common cause of death after cardiac failure in LVAD patients. All infections must be aggressively treated to avoid seeding the device. Device thrombosis can develop even when patients are adequately anticoagulated and taking antiplatelet therapy because the LVAD is responsible for a chronic hypercoagulable state. Conclusion: Management of these unique patients in the ICU is best accomplished with a multidisciplinary team that includes specialists in advanced heart failure, LVAD nurse coordinators and intensivists. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:292 / 300
页数:9
相关论文
共 31 条
[1]   Quality of life with an LVAD: A misunderstood concept [J].
Adams, Emily E. ;
Wrightson, Morgan L. .
HEART & LUNG, 2018, 47 (03) :177-183
[2]   Management of end-stage heart failure patients with or without ventricular assist device: an observational comparison of clinical and economic outcomes [J].
Aissaoui, Nadia ;
Morshuis, Michiel ;
Maoulida, Hassani ;
Salem, Joe-Elie ;
Lebreton, Guillaume ;
Brunn, Matthias ;
Chatellier, Gilles ;
Hagege, Albert ;
Schoenbrodt, Michael ;
Puymirat, Etienne ;
Latremouille, Christian ;
Varnous, Shaida ;
Ouldamar, Salima ;
Guillemain, Romain ;
Diebold, Benoit ;
Guedeney, Paul ;
Barreira, Marc ;
Mutuon, Pierre ;
Guerot, Emmanuel ;
Paluszkiewicz, Lech ;
Hakim-Meibodi, Kavous ;
Schulz, Uwe ;
Danchin, Nicolas ;
Gummert, Jan ;
Durand-Zaleski, Isabelle ;
Leprince, Pascal ;
Fagon, Jean-Yves .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (01) :170-177
[3]   Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables [J].
Aissaoui, Nadia ;
Salem, Joe-Elie ;
Paluszkiewicz, Lech ;
Morshuis, Michiel ;
Guerot, Emmanuel ;
Gorria, Gonzalo Martin ;
Fagon, Jean-Yves ;
Gummert, Jan ;
Diebold, Benoit .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2015, 108 (05) :300-309
[4]   Comparison of Biventricular and Left Ventricular Assist Devices for the Management of Severe Right Ventricular Dysfunction in Patients with End-Stage Heart Failure [J].
Aissaoui, Nadia ;
Morshuis, Michiel ;
Paluszkiewicz, Lech ;
Lauenroth, Volker ;
Boergermann, Jochen ;
Gummert, Jan .
ASAIO JOURNAL, 2014, 60 (04) :400-406
[5]   Temporary right ventricular mechanical circulatory support for the management of right ventricular failure in critically ill patients [J].
Aissaoui, Nadia ;
Morshuis, Michiel ;
Schoenbrodt, Michael ;
Meibodi, Kavous Hakim ;
Kizner, Lukasz ;
Boergermann, Jochen ;
Gummert, Jan .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (01) :186-191
[6]   Heart failure while on ventricular assist device support: A true clinical entity? [J].
Aissaoui, Nadia ;
Morshuis, Michiel ;
Diebold, Benoit ;
Guerot, Emmanuel ;
Gummert, Jan .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (01) :44-51
[7]   HeartWare continuous-flow ventricular assist device thrombosis: The Bad Oeynhausen experience [J].
Aissaoui, Nadia ;
Boergermann, Jochen ;
Gummert, Jan ;
Morshuis, Michiel .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 143 (04) :E37-E39
[8]   Ethical Challenges With Deactivation of Durable Mechanical Circulatory Support at the End of Life: Left Ventricular Assist Devices and Total Artificial Hearts [J].
不详 .
JOURNAL OF INTENSIVE CARE MEDICINE, 2014, 29 (01) :3-12
[9]   The Incidence, Risk, and Consequences of Atrial Arrhythmias in Patients with Continuous-Flow Left Ventricular Assist Devices [J].
Brisco, Meredith A. ;
Sundareswaran, Kartik S. ;
Milano, Carmelo A. ;
Feldman, David ;
Testani, Jeffrey M. ;
Ewald, Gregory A. ;
Slaughter, Mark S. ;
Farrar, David J. ;
Goldberg, Lee R. .
JOURNAL OF CARDIAC SURGERY, 2014, 29 (04) :572-580
[10]   High Incidence of Thromboembolic Events in Left Ventricular Assist Device Patients Treated With Recombinant Activated Factor VII [J].
Bruckner, Brian A. ;
DiBardino, Daniel J. ;
Ning, Qian ;
Adeboygeun, Alfred ;
Mahmoud, Karim ;
Valdes, Jamie ;
Eze, John ;
Allison, Paul M. ;
Cooley, Denton A. ;
Gregoric, Igor D. ;
Frazier, Oscar H. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (08) :785-790